Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 177

1.

The transmissibility and control of pandemic influenza A (H1N1) virus.

Yang Y, Sugimoto JD, Halloran ME, Basta NE, Chao DL, Matrajt L, Potter G, Kenah E, Longini IM Jr.

Science. 2009 Oct 30;326(5953):729-33. doi: 10.1126/science.1177373. Epub 2009 Sep 10.

2.

Strategies for pandemic and seasonal influenza vaccination of schoolchildren in the United States.

Basta NE, Chao DL, Halloran ME, Matrajt L, Longini IM Jr.

Am J Epidemiol. 2009 Sep 15;170(6):679-86. doi: 10.1093/aje/kwp237. Epub 2009 Aug 13.

3.

Modeling optimal age-specific vaccination strategies against pandemic influenza.

Lee S, Golinski M, Chowell G.

Bull Math Biol. 2012 Apr;74(4):958-80. doi: 10.1007/s11538-011-9704-y. Epub 2011 Dec 7.

PMID:
22147102
4.

Potential for a global dynamic of Influenza A (H1N1).

Flahault A, Vergu E, Boëlle PY.

BMC Infect Dis. 2009 Aug 12;9:129. doi: 10.1186/1471-2334-9-129.

5.

Vaccines against influenza A (H1N1) pandemic.

Valdespino-Gomez JL, Garcia-Garcia L, de León-Rosales SP.

Arch Med Res. 2009 Nov;40(8):693-704. doi: 10.1016/j.arcmed.2009.10.008.

PMID:
20304259
6.

Effectiveness of 2008-09 trivalent influenza vaccine against 2009 pandemic influenza A (H1N1) - United States, May-June 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1241-5.

7.

Adaptive vaccination strategies to mitigate pandemic influenza: Mexico as a case study.

Chowell G, Viboud C, Wang X, Bertozzi SM, Miller MA.

PLoS One. 2009 Dec 3;4(12):e8164. doi: 10.1371/journal.pone.0008164.

8.

Characterizing the epidemiology of the 2009 influenza A/H1N1 pandemic in Mexico.

Chowell G, Echevarría-Zuno S, Viboud C, Simonsen L, Tamerius J, Miller MA, Borja-Aburto VH.

PLoS Med. 2011 May;8(5):e1000436. doi: 10.1371/journal.pmed.1000436. Epub 2011 May 24.

9.

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City.

Garcia-Garcia L, Valdespino-Gómez JL, Lazcano-Ponce E, Jimenez-Corona A, Higuera-Iglesias A, Cruz-Hervert P, Cano-Arellano B, Garcia-Anaya A, Ferreira-Guerrero E, Baez-Saldaña R, Ferreyra-Reyes L, Ponce-de-León-Rosales S, Alpuche-Aranda C, Rodriguez-López MH, Perez-Padilla R, Hernandez-Avila M.

BMJ. 2009 Oct 6;339:b3928. doi: 10.1136/bmj.b3928.

10.

Planning for the next influenza H1N1 season: a modelling study.

Carrat F, Pelat C, Levy-Bruhl D, Bonmarin I, Lapidus N.

BMC Infect Dis. 2010 Oct 21;10:301. doi: 10.1186/1471-2334-10-301.

11.

Absence of cross-reactive antibodies to influenza A (H1N1) 2009 before and after vaccination with 2009 Southern Hemisphere seasonal trivalent influenza vaccine in children aged 6 months-9 years: a prospective study.

McVernon J, Laurie K, Barr I, Kelso A, Skeljo M, Nolan T.

Influenza Other Respir Viruses. 2011 Jan;5(1):7-11. doi: 10.1111/j.1750-2659.2010.00172.x. Epub 2010 Aug 24.

12.

Pandemic influenza. Europe reconsiders H1N1 flu shots for children.

Enserink M.

Science. 2009 Nov 13;326(5955):922. doi: 10.1126/science.326.5955.922. No abstract available.

PMID:
19965485
13.

Seasonal influenza vaccine and protection against pandemic (H1N1) 2009-associated illness among US military personnel.

Johns MC, Eick AA, Blazes DL, Lee SE, Perdue CL, Lipnick R, Vest KG, Russell KL, DeFraites RF, Sanchez JL.

PLoS One. 2010 May 19;5(5):e10722. doi: 10.1371/journal.pone.0010722.

14.

[Principles and methods for vaccine epidemiology: evaluation of immunogenicity and effectiveness of pandemic H1N1 influenza vaccine].

Hara M, Ohfuji S, Fukushima W, Hirota Y.

Nihon Eiseigaku Zasshi. 2013;68(3):153-60. Review. Japanese.

15.

2009 Pandemic influenza A virus subtype H1N1 in Morocco, 2009-2010: epidemiology, transmissibility, and factors associated with fatal cases.

Barakat A, Ihazmad H, El Falaki F, Tempia S, Cherkaoui I, El Aouad R.

J Infect Dis. 2012 Dec 15;206 Suppl 1:S94-100. doi: 10.1093/infdis/jis547.

16.

Modelling mitigation strategies for pandemic (H1N1) 2009.

Gojovic MZ, Sander B, Fisman D, Krahn MD, Bauch CT.

CMAJ. 2009 Nov 10;181(10):673-80. doi: 10.1503/cmaj.091641. Epub 2009 Oct 13.

17.
18.

Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.

Bateman AC, Kieke BA, Irving SA, Meece JK, Shay DK, Belongia EA.

J Infect Dis. 2013 Apr 15;207(8):1262-9. doi: 10.1093/infdis/jit020. Epub 2013 Jan 22.

PMID:
23341536
19.

Vaccination deep into a pandemic wave potential mechanisms for a "third wave" and the impact of vaccination.

Lee BY, Brown ST, Cooley P, Grefenstette JJ, Zimmerman RK, Zimmer SM, Potter MA, Rosenfeld R, Wheaton WD, Wiringa AE, Bacon KM, Burke DS.

Am J Prev Med. 2010 Nov;39(5):e21-9. doi: 10.1016/j.amepre.2010.07.014.

20.

Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.

Blank PR, Bonnelye G, Ducastel A, Szucs TD.

PLoS One. 2012;7(10):e45450. doi: 10.1371/journal.pone.0045450. Epub 2012 Oct 11.

Supplemental Content

Support Center